News Releases

March 28, 2014

Glaxosmithkline Announces Voluntary Recall of AlliĀ® Due to Product Tampering

The Missouri Department of Health and Senior Services received information regarding a recall of all alli® weight loss products from U.S. and Puerto Rico retailers as the company believes that some packages of the product were tampered with and may contain product that is not authentic alli®. GSK is conducting an investigation and is working with the knowledge of the U.S. Food and Drug Administration (FDA) on this retailer level recall. GSK received inquiries from consumers in seven states about bottles of alli® that contained tablets and capsules that were not alli®. A range of tablets and capsules of various shapes and colors were reported to be found inside bottles.

Additionally, some bottles inside the outer carton were missing labels and had tamper-evident seals that were not authentic. These tampered products were purchased in retail stores. A Consumer Alert has been posted to: www.myalli.com, and a news release has been issued with information and photographs to help consumers determine if their alli is authentic." alli® is a turquoise blue capsule with a dark blue band imprinted with the text "60 Orlistat". It is packaged in a labeled bottle that has an inner foil seal imprinted with the words: "Sealed for Your Protection." Consumers should confirm any alli® in their possession matches this description. Pictures of the product are available at: www.myalli.com.

Consumers who have product they are unsure or concerned about should not use it. Instead, they should call GSK promptly at 800-671-2554, and a representative will provide further instructions. If they have consumed questionable product, they should also contact their healthcare providers.

The full recall can be found at: http://www.fda.gov/Safety/Recalls/ucm391004.htm?source=govdelivery&utm_medium=email&utm_source=govdelivery.

###